Evidence map›Paper›PMID 31035376›Full record

ReviewNutrients2019

What Evidence Do We Have for Pharmaceutical Galactagogues in the Treatment of Lactation Insufficiency?-A Narrative Review.

Luke E Grzeskowiak, Mary E Wlodek, Donna T Geddes

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04614714 (Nicotinamide Riboside and Milk Production in the NICU), which is not on this map. Cited by 26 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 4 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04614714 phase2 / phase3not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Nicotinamide Riboside and Milk Production in the NICU

TypeinterventionalSponsorUniversity of California, DavisRan2026 to 2026Enrolled40ConditionsPreterm Birth, Inadequate Milk ProductionArmsNicotinamide Riboside (NR), Placebo
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 4 syntheses or guidelines pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Breastfeeding interventions for preventing postpartum depression.The Cochrane database of systematic reviews · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The Aqueous Extract ofFoods (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Article
  14. Lactation in the human.Animal frontiers : the review magazine of animal agriculture · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Luke E GrzeskowiakAdelaide Medical School, Robinson Research Institute, The University of Adelaide, Adelaide, SA 5005, Australia. luke.Grzeskowiak@adelaide.edu.au.ORCID 0000-0001-8554-4696
Mary E WlodekDepartment of Physiology, The University of Melbourne, Melbourne, VIC 3010, Australia. m.wlodek@unimelb.edu.au.
Donna T GeddesSchool of Molecular Sciences, The University of Western Australia, Crawley, Perth, WA 6009, Australia. donna.geddes@uwa.edu.au.
Flinders Medical Centre · AUThe University of Melbourne · AUThe University of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inadequate breast milk supply is a frequently reported reason for early discontinuation of breastfeeding and represents a critical opportunity for intervening to improve breastfeeding outcomes. For women who continue to experience insufficient milk supply despite the utilisation of non-pharmacological lactation support strategies, pharmacological intervention with medications used to augment lactation, commonly referred to as galactagogues, is common. Galactagogues exert their pharmacological effects through altering the complex hormonal milieu regulating lactation, particularly prolactin and oxytocin. This narrative review provides an appraisal of the existing evidence regarding the efficacy and safety of pharmaceutical treatments for lactation insufficiency to guide their use in clinical practice. The greatest body of evidence surrounds the use of domperidone, with studies demonstrating moderate short-term improvements in breast milk supply. Evidence regarding the efficacy and safety of metoclopramide is less robust, but given that it shares the same mechanism of action as domperidone it may represent a potential treatment alternative where domperidone is unsuitable. Data on remaining interventions such as oxytocin, prolactin and metformin is too limited to support their use in clinical practice. The review provides an overview of key evidence gaps and areas of future research, including the impacts of pharmaceutical galactagogues on breast milk composition and understanding factors contributing to individual treatment response to pharmaceutical galactagogues.

Indexed as

DomperidoneDopamine AntagonistsFemaleGalactogoguesHumansLactationDomperidoneDopamine AntagonistsGalactogoguesbreast feedingbreast milkgalactagogueslactationlow milk supply

Identifiers

PMID31035376
PMCPMC6567188
OpenAlexW2940796663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.